The Fate of Osteoblast-Like MG-63 Cells on Pre-Infected Bactericidal Nanostructured Titanium Surfaces
AbstractBiomaterials that have been newly implanted inside the body are the substratum targets for a “race for the surface”, in which bacterial cells compete against eukaryotic cells for the opportunity to colonize the surface. A victory by the former often results in biomaterial-associated infections, which can be a serious threat to patient health and can undermine the function and performance of the implant. Moreover, bacteria can often have a ‘head start’ if implant contamination has taken place either prior to or during the surgery. Current prevention and treatment strategies often rely on systemic antibiotic therapies, which are becoming increasingly ineffective due to a growing prevalence of antibiotic-resistant bacteria. Nanostructured surfaces that kill bacteria by physically rupturing bacterial cells upon contact have recently emerged as a promising solution for the mitigation of bacterial colonization of implants. Furthermore, these nanoscale features have been shown to enhance the adhesion and proliferation of eukaryotic cells, which is a key to, for example, the successful osseointegration of load-bearing titanium implants. The bactericidal activity and biocompatibility of such nanostructured surfaces are often, however, examined separately, and it is not clear to what extent bacterial cell-surface interactions would affect the subsequent outcomes of host-cell attachment and osseointegration processes. In this study, we investigated the ability of bactericidal nanostructured titanium surfaces to support the attachment and growth of osteoblast-like MG-63 human osteosarcoma cells, despite them having been pre-infected with pathogenic bacteria. MG-63 is a commonly used osteoblastic model to study bone cell viability, adhesion, and proliferation on the surfaces of load-bearing biomaterials, such as titanium. The nanostructured titanium surfaces used here were observed to kill the pathogenic bacteria, whilst simultaneously enhancing the growth of MG-63 cells in vitro when compared to that occurring on sterile, flat titanium surfaces. These results provide further evidence in support of nanostructured bactericidal surfaces being used as a strategy to help eukaryotic cells win the “race for the surface” against bacterial cells on implant materials. View Full-Text
- Supplementary File 1:
PDF-Document (PDF, 546 KB)
Share & Cite This Article
Wandiyanto, J.V.; Truong, V.K.; Al Kobaisi, M.; Juodkazis, S.; Thissen, H.; Bazaka, O.; Bazaka, K.; Crawford, R.J.; Ivanova, E.P. The Fate of Osteoblast-Like MG-63 Cells on Pre-Infected Bactericidal Nanostructured Titanium Surfaces. Materials 2019, 12, 1575.
Wandiyanto JV, Truong VK, Al Kobaisi M, Juodkazis S, Thissen H, Bazaka O, Bazaka K, Crawford RJ, Ivanova EP. The Fate of Osteoblast-Like MG-63 Cells on Pre-Infected Bactericidal Nanostructured Titanium Surfaces. Materials. 2019; 12(10):1575.Chicago/Turabian Style
Wandiyanto, Jason V.; Truong, Vi K.; Al Kobaisi, Mohammad; Juodkazis, Saulius; Thissen, Helmut; Bazaka, Olha; Bazaka, Kateryna; Crawford, Russell J.; Ivanova, Elena P. 2019. "The Fate of Osteoblast-Like MG-63 Cells on Pre-Infected Bactericidal Nanostructured Titanium Surfaces." Materials 12, no. 10: 1575.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.